Name:
(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
Type:
AKA:
FUB-144
(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone image
Synthetic substance, no natural derivative
IUPAC Logo
(1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone image
This compound is a synthetic cannabinoid developed in the 2000s. It is part of the ongoing research into cannabinoids and their effects on the endocannabinoid system. Like other synthetic cannabinoids, it has been studied for its potential therapeutic applications but is regulated due to its psychoactive properties and abuse potential.
Synthetic Substances Image
This substance, a synthetic cannabinoid, produces intense psychoactive effects. As an upper, it induces euphoria and altered perception. Short-term effects include heightened sensory experiences, while long-term use can lead to psychological issues. Overdose risks include severe agitation and psychosis. Safe use involves cautious dosing, and recent research highlights its potency and associated risks.
N/A
This synthetic cannabinoid induces euphoria and altered perception. Immediate effects include mood elevation and sensory distortion. Long-term use may result in severe anxiety, psychosis, and cognitive impairments. Recent studies highlight its high abuse potential and significant psychological risks associated with synthetic cannabinoids.
N/A
This synthetic cannabinoid is one of many designed to mimic the effects of THC, the active component in cannabis. Synthetic cannabinoids have emerged as popular alternatives to marijuana, often marketed as 'legal highs.' Their unpredictable effects and high potency have led to numerous health incidents, and they are often associated with marginalized communities seeking affordable highs. Historically, cannabis has been used in religious and medicinal contexts in various cultures, including ancient China and India. The modern use of synthetic cannabinoids has raised concerns about public health, leading to regulatory crackdowns and ongoing debates about cannabis legalization and the safety of synthetic alternatives.
N/A